Skip to main content
OpenTrials

Clinical trial condition

Pancreatic Ductal Adenocarcinoma

Explore clinical trials studying Pancreatic Ductal Adenocarcinoma. Study availability and eligibility vary by location and protocol.

185 public trials 75 recruiting studies
Refine in advanced search Browse all conditions

Pancreatic Ductal Adenocarcinoma trial results

Recruiting

A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations

NCT07629960

Conditions
Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, Bronchogenic, +29 more
Locations
  • Next Oncology Virginia Cancer Specialist Fairfax, Virginia, United States
  • Florida Cancer Specialists & Research Institute - Sarasota Sarasota, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Mary Bird Perkins Cancer Center Baton Rouge, Louisiana, United States
View all 16 locations
View Trial Details
Recruiting

A Study of NALIRIFOX in Combination With Radiation Therapy in People With Pancreatic Ductal Adenocarcinoma (PDAC)

NCT05851924

Conditions
Pancreatic Ductal Adenocarcinoma
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk- Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

POP-UP: a Single-arm, Two-cohort Study: an 8-week Trimodal Pre-habilitation Program for Patients With Pancreatic Ductal Adenocarcinoma and Oesogastric

NCT06275737

Conditions
Digestive System Diseases, Digestive System Neoplasms, Esophageal Cancer, +8 more
Locations
  • Centre Hospitalier Universitaire Dijon Bourgogne Dijon, France
  • Institut Daniel Hollard - Groupe Hospitalier Mutualiste de Grenoble Grenoble, France
  • Centre Hospitalier Universitaire de Lille Lille, France
  • Hospital La Timone Marseille, France
View Trial Details
Recruiting

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

NCT06673017

Conditions
Borderline Resectable Pancreatic Adenocarcinoma, Digestive System Diseases, Digestive System Neoplasms, +9 more
Locations
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Northwell Health Zuckerberg Cancer Center Lake Success, New York, United States
  • University of Texas Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Recruiting

Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature

NCT05314998

Conditions
Pancreatic Ductal Adenocarcinoma
Locations
  • Universitätsklinikum Aachen, Studienzentrum Viszeralmedizin Klinik für Allgemeine-, Viszeral und Transplatationschirurgie Aachen, Germany
  • Universitätsklinikum Augsburg, III. medizinische Klinik Augsburg, Germany
  • St. Josef-Hospital, Klinikum der Ruhr-Universität Bochum, Abteilung für Hämatologie, Onkologie und Palliativmedizin, Studienambulanz Bochum, Germany
  • Universitätsklinikum Bonn, Chirurgische Abteilung Bonn, Germany
View all 33 locations
View Trial Details
Recruiting

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

NCT04851119

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +90 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 21 locations
View Trial Details

Related conditions